CSIMarket
 


Cryoport inc   (CYRX)
Other Ticker:  
 

Cryoport Inc 's Leverage Ratio

CYRX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 1.21%, Leverage Ratio fell to 0.96, above the Cryoport Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the forth quarter 2023, 101 other companies have achieved lower Leverage Ratio than Cryoport Inc in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 1001, from total ranking in the third quarter 2023 at 1681 .

Explain Leverage Ratio?
Who are CYRX Customers?
What are CYRX´s Total Liabilities?


CYRX Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -12.02 % -3.27 % -4.25 % -8.03 % -13.4 %
Y / Y Total Liabilities Change -2.07 % -2.38 % 2.52 % 4.21 % 2.49 %
Leverage Ratio MRQ 0.96 0.86 0.89 0.87 0.86
CYRX's Total Ranking # 1001 # 1681 # 1830 # 1867 # 2125
Seq. Equity Change -9.02 % -1.24 % -2.9 % 0.84 % 0.02 %
Seq. Total Liabilities Change 1.21 % -4.78 % -0.25 % 1.87 % 0.89 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 102
Healthcare Sector # 236
Overall Market # 1001


Leverage Ratio Statistics
High Average Low
5.8 0.71 0.07
(Dec 31 2011)   (Dec 31 2019)




Financial Statements
Cryoport Inc 's Equity $ 489 Millions Visit CYRX's Balance sheet
Cryoport Inc 's Total Liabilities $ 469 Millions Visit CYRX's Balance sheet
Source of CYRX's Sales Visit CYRX's Sales by Geography


Cumulative Cryoport Inc 's Leverage Ratio

CYRX's Leverage Ratio for the trailling 12 Months

CYRX Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -12.02 % -3.27 % -4.25 % -8.03 % -13.4 %
Y / Y Total Liabilities TTM Growth -2.07 % -2.38 % 2.52 % 4.21 % 2.49 %
Leverage Ratio TTM 0.89 0.87 0.87 0.85 0.83
Total Ranking TTM # 849 # 8 # 1553 # 6 # 699
Seq. Equity TTM Growth -9.02 % -1.24 % -2.9 % 0.84 % 0.02 %
Seq. Total Liabilities TTM Growth 1.21 % -4.78 % -0.25 % 1.87 % 0.89 %


On the trailing twelve months basis Due to the net new borrowings of 1.21% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeLeverage Ratio improved to 0.89, above the Cryoport Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 86, during the past 12 months, other companies have achieved lower Leverage Ratio than Cryoport Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the IV Quarter 2023, compared to the prior period, from 8 to 849.

Explain Leverage Ratio?
Who are CYRX Customers?
What are CYRX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 87
Healthcare Sector # 214
Within the Market # 849


trailing twelve months Leverage Ratio Statistics
High Average Low
1.41 0.48 0.12
(Sep. 30, 2015)   (Sep 30 2018)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
G1 Therapeutics Inc   2.43 $ 86.154  Millions$ 35.386  Millions
Proqr Therapeutics N v   2.33 $ 108.072  Millions$ 46.357  Millions
Phibro Animal Health Corporation  2.31 $ 626.625  Millions$ 270.803  Millions
Bristol myers Squibb Company  2.23 $ 65,729.000  Millions$ 29,485.000  Millions
Alimera Sciences Inc   2.00 $ 92.218  Millions$ 46.170  Millions
Biovie Inc   1.87 $ 13.981  Millions$ 7.491  Millions
Zoetis Inc   1.86 $ 9,289.000  Millions$ 4,991.000  Millions
Emergent Biosolutions Inc   1.81 $ 1,173.900  Millions$ 649.300  Millions
Jazz Pharmaceuticals Plc  1.78 $ 6,644.680  Millions$ 3,736.997  Millions
Catalent Inc   1.71 $ 6,301.000  Millions$ 3,687.000  Millions
Xoma Corporation  1.64 $ 145.580  Millions$ 88.721  Millions
Summit Therapeutics Inc   1.61 $ 125.257  Millions$ 77.692  Millions
Cumberland Pharmaceuticals Inc  1.59 $ 46.528  Millions$ 29.260  Millions
Merck and Co Inc   1.58 $ 59,431.000  Millions$ 37,635.000  Millions
Pfizer Inc  1.54 $ 137,487.000  Millions$ 89,288.000  Millions
Ocular Therapeutix Inc   1.54 $ 139.916  Millions$ 91.131  Millions
Liquidia Corporation  1.50 $ 71.039  Millions$ 47.293  Millions
Viatris Inc   1.33 $ 27,218.100  Millions$ 20,467.400  Millions
Lifevantage Corp  1.30 $ 35.375  Millions$ 27.307  Millions
Verastem inc   1.24 $ 71.185  Millions$ 57.374  Millions
2seventy Bio Inc   1.21 $ 310.126  Millions$ 255.300  Millions
Cara Therapeutics inc   1.20 $ 68.759  Millions$ 57.085  Millions
Sonoma Pharmaceuticals Inc   1.18 $ 7.926  Millions$ 6.692  Millions
Perrigo Company Plc  1.18 $ 5,615.400  Millions$ 4,767.900  Millions
Elanco Animal Health Inc  1.16 $ 7,205.000  Millions$ 6,223.000  Millions
Johnson and Johnson  1.16 $ 79,590.000  Millions$ 68,774.000  Millions
Novartis Ag  1.14 $ 53,195.000  Millions$ 46,750.000  Millions
Ani Pharmaceuticals Inc  1.09 $ 471.673  Millions$ 432.749  Millions
Prestige Consumer Healthcare Inc   1.09 $ 1,739.176  Millions$ 1,600.577  Millions
Assertio Holdings inc   1.08 $ 148.416  Millions$ 138.003  Millions

Date modified: 2024-03-13T23:04:03+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com